BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 14696936)

  • 1. Response surface optimization of a vortex-assisted dispersive liquid-liquid microextraction method for highly sensitive determination of repaglinide in environmental water by HPLC/UV.
    Kamal AH; Hammad MA; Kannouma RE; Mansour FR
    BMC Chem; 2022 May; 16(1):33. PubMed ID: 35568922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability-indicating assay of repaglinide in bulk and optimized nanoemulsion by validated high performance thin layer chromatography technique.
    Akhtar J; Fareed S; Aqil M
    J Pharm Bioallied Sci; 2013 Jul; 5(3):184-90. PubMed ID: 24082694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of UV spectrophotometry and high performance liquid chromatography methods for the determination of repaglinide in tablets.
    Dhole SM; Khedekar PB; Amnerkar ND
    Pharm Methods; 2012 Jul; 3(2):68-72. PubMed ID: 23781481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validated stability-indicating spectrofluorimetric method with enhanced sensitivity for determination of repaglinide in tablets.
    El-Shaheny RN
    J Fluoresc; 2012 Nov; 22(6):1587-94. PubMed ID: 22752435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Spectrofluorimetric and HPLC Methods for In vitro Analysis of Repaglinide.
    Kaushal N; Jain S; Tiwary AK
    Indian J Pharm Sci; 2010 Mar; 72(2):240-4. PubMed ID: 20838532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring ibuprofen release from multiparticulates: in situ fiber-optic technique versus the HPLC method: a technical note.
    Bijlani V; Yuonayel D; Katpally S; Chukwumezie BN; Adeyeye MC
    AAPS PharmSciTech; 2007 Jul; 8(3):E52. PubMed ID: 17915802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Column-Switching Methods in HPLC for Evaluating Pharmacokinetic Parameters.
    Lee HJ; Kim KB
    Adv Chromatogr; 2011; 49():291-340. PubMed ID: 26434240
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulations.
    Berecka A; Gumieniczek A; HopkaƂa H
    J AOAC Int; 2006; 89(2):319-25. PubMed ID: 16640279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of first-derivative spectrophotometry and column high-performance liquid chromatography applied to the determination of repaglinide in tablets and for dissolution testing.
    AlKhalidi BA; Shtaiwi M; AlKhatib HS; Mohammad M; Bustanji Y
    J AOAC Int; 2008; 91(3):530-5. PubMed ID: 18567297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs.
    Yao J; Shi YQ; Li ZR; Jin SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):254-9. PubMed ID: 17409031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies.
    Ruzilawati AB; Wahab MS; Imran A; Ismail Z; Gan SH
    J Pharm Biomed Anal; 2007 Apr; 43(5):1831-5. PubMed ID: 17240100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine).
    El-Zaher AA; Elkady EF; Elwy HM; Saleh MA
    J AOAC Int; 2016 Jul; 99(4):957-963. PubMed ID: 27214744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of repaglinide in pharmaceutical formulations by HPLC with UV detection.
    Gandhimathi M; Ravi TK; Renu SK
    Anal Sci; 2003 Dec; 19(12):1675-7. PubMed ID: 14696936
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.